A study on the effect of safoof e gulnar versus tranexamic acid in Menorrhagia due to polycystic ovarian syndrome

A Comparative clinical study to evaluate the the efficacy of safoof e Gulnar with Tranexamic acid in the management of menorrhagia ( kathrat-i-Tamth) due To Akyas khusytur Rahem polycystic ovarian syndrome. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084365

Enrollment

Registered

2025-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: 1.Gulnar(punica granatum Linn): Patient of group A will be given 2.5gram of gulnar powder per day in capsule form in two divided doses for period of 5 days in each month for 3 consecuti

Eligibility

Inclusion criteria

Inclusion criteria: 1.pcos diagnosed based on Rotterdam criteria. 2.Excessive bleeding more than 7 days. 3. Patient having a history of excessive bleeding in at least 2-3 cycles

Exclusion criteria

Exclusion criteria: 1.pregnancy. 2. Patient having Hb% less than 7 and Hematological disorder. 3.fibroid uterus.

Design outcomes

Primary

Measure	Time frame
To reduce the score of pictorial blood assessment chart (PBAC).Timepoint: 12 weeks	—

Secondary

Measure	Time frame
To reduce the score of pictorial blood assessment chart (PBAC)Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Shahzadi Sultana

Government Nizamia Tibbi college and General Hospital

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026